Suppr超能文献

靶向周细胞可减少前列腺癌中的新生血管形成和淋巴管生成。

Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.

作者信息

Ozerdem Ugur

机构信息

La Jolla Institute for Molecular Medicine, San Diego, California 92121, USA.

出版信息

Prostate. 2006 Feb 15;66(3):294-304. doi: 10.1002/pros.20346.

Abstract

BACKGROUND

The walls of capillaries in prostate cancer are composed of endothelial cells, and pericytes. NG2 is a transmembrane proteoglycan on nascent pericytes with a functional role in neovascularization.

METHODS

The anti-angiogenic effect of hydron pellets containing NG2 neutralizing antibody was quantified in intracorneal PC-3 and LNCaP xenografts. TRAMP and TRAMP-C1 tumors grafted in NG2 knockout mice represented intrinsic pericyte targeting. TRAMP and TRAMP-C1 grafts were analyzed with confocal microscope for microvascular density (MVD) and lymphatic vascular density (LVD).

RESULTS

NG2 neutralizing antibody decreased corneal neovascularization in PC3 (P<0.0001), and LNCaP (P=0.0079) xenografts. Mean MVD in TRAMP and TRAMP-C1 tumors in NG2 knockout mice were 71% (P=0.0006) and 63% (P=0.0011) lower than wild type controls, respectively. Mean LVD in TRAMP and TRAMP-C1 tumors in NG2 knockout mice were 73% (P=0.0003) and 84% (P<0.0001) lower than wild type controls, respectively.

CONCLUSIONS

Targeting of pericyte-NG2 decreases neovascularization and lymphangiogenesis in prostate cancer significantly.

摘要

背景

前列腺癌毛细血管壁由内皮细胞和周细胞组成。NG2是新生周细胞上的一种跨膜蛋白聚糖,在新血管形成中起作用。

方法

在角膜内PC-3和LNCaP异种移植模型中,对含NG2中和抗体的氢粒子的抗血管生成作用进行定量分析。移植到NG2基因敲除小鼠体内的TRAMP和TRAMP-C1肿瘤代表了对周细胞的内在靶向作用。用共聚焦显微镜分析TRAMP和TRAMP-C1移植瘤的微血管密度(MVD)和淋巴管密度(LVD)。

结果

NG2中和抗体降低了PC3(P<0.0001)和LNCaP(P=0.0079)异种移植瘤的角膜新生血管形成。NG2基因敲除小鼠中TRAMP和TRAMP-C1肿瘤的平均MVD分别比野生型对照低71%(P=0.0006)和63%(P=0.0011)。NG2基因敲除小鼠中TRAMP和TRAMP-C1肿瘤的平均LVD分别比野生型对照低73%(P=0.0003)和84%(P<0.0001)。

结论

靶向周细胞-NG2可显著降低前列腺癌的新生血管形成和淋巴管生成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验